Navigation Links
Renovar captures $1.2M for product development

Madison, Wis. - An early-stage company developing diagnostics to test for kidney disease is preparing to use $1.22 million in private investments to secure federal clearance for its first clinical product.

Renovar, Inc., which has raised a total of $3.2 million since its inception in 1999, will use the proceeds from its second financing rou......

Full article >>> ing used in research settings, involves a proprietary buffer that enables scientists to detect protiens that appear in urine and could indicate inflammation or injury.

"That gives us a window into the disease state of the kidney," Hedberg said.

......

Full article >>>
'"/>

Source:wistechnology.com By Chris Fleissner 11/30/06


Related biology technology :

1. Blurb shows that print still captures imaginations
2. Alzheimers drug developer lands $1.2M in venture funding
3. cMaster RTplusPCR System for increased sensitivity and product length in RT-PCR
4. Advantages of Roche Applied Science amplification products
5. Find the optimal product for your PCR application
6. Trouble-shooting: No product
7. Find the optimal product for your application
8. Microfluidic analysis of multiplex PCR products for the genotyping of Helicobacter pylori
9. Determination of the Chloramphenicol residues in milk and milk products using LC/MS/MS
10. Using THERMAL DESORPTION GAS CHROMATOGRAPHY for the identification of fragrance and other components in cosmetic products
11. WARF enters licensing agreements for stem cell products
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/22/2017)... , March 22, 2017 Good Start ... it has eclipsed the 130 million covered lives mark ... Shield of Texas . With newly ... Company continues to enjoy strong payor acceptance based on ... clinical programs and genetic counseling, its industry-leading customer care ...
(Date:3/22/2017)... New York , March 22, 2017 ... is largely fragmented, states a research report by Transparency ... S.A., Pfizer Inc., Amgen Inc., and AbbVie Inc., accounted ... in 2015. The prominent players in this market are ... expand their product portfolio, which is likely to lead ...
(Date:3/22/2017)... , March 22, 2017   Boston Biomedical , ... therapeutics designed to target cancer stemness pathways, today announced ... Andrews as Chief Executive Officer, effective April 24, ... Chiang J. Li , M.D., FACP, who has led ... ago. Under his leadership, Boston Biomedical has grown from ...
(Date:3/22/2017)... ... March 21, 2017 , ... Okyanos Cell Therapy has announced Tallahassee, FL ... live events series, “Stem Cell Therapy: The Next Phase in the Evolution of Medicine.” ... Stem Cell Research and Therapy Act, Okyanos maintains a mission to help “no-option” ...
Breaking Biology Technology:
(Date:3/2/2017)... LONDON , March 2, 2017 Summary ... require to better understand Merck KGaA and its partnering ... report: https://www.reportbuyer.com/product/3605601/ Description The Partnering Deals ... into the partnering activity of one of the world,s ... reports are prepared upon purchase to ensure inclusion of ...
(Date:2/28/2017)... LOS ANGELES , Feb. 28, 2017   ... identity verification software globally, announces significant enhancements to new ... in May 2016. New products include mobile and desktop ... and DocX TM - a real time manual ... Acuant,s core idScan® technology provides the fastest and most ...
(Date:2/26/2017)... , Feb. 25, 2017  Securus Technologies, ... technology solutions for public safety, investigation, corrections and ... Recidivism and Reentry. "Too often, too ... prisons and county jails are trying to tackle ... inmates and friends and family members. While significant steps ...
Breaking Biology News(10 mins):